Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (CIDUS III/DUIT)
Sponsor: Centers for Disease Control and Prevention
Listed as NCT00164372, this PHASE2/PHASE3 trial focuses on HIV Infections and Hepatitis C and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 5 times since 2002, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
May 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .